Paradigm Biopharmaceuticals Ltd.ASX: PAR

Trading Halt

Sep 20, 2026 at 6:47 PM EDT · Issued by Paradigm Biopharmaceuticals Ltd. via ASX

Filed with ASX · Sep 20, 2026 at 6:47 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/trading-halt-2026

Release

Market Announcement 21 September 2026 21 September 2026 Market Announcement 1/1 ASX Limited ASX Customer Service Centre 131 279 | asx.com.au #11142542v1 Paradigm Biopharmaceuticals Limited (ASX: PAR) – Trading Halt Trading in the securities of Paradigm Biopharmaceuticals Limited...

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

Application for quotation of securities - PARSep 17
Dr Daniel Furtner appointed Chief Medical OfficerSep 14
Notice under Section 708ASep 10
Notification regarding unquoted securities - PARSep 10
Drawdown of Tranche 4 under the Convertible Note FacilitySep 10

Later from Paradigm Biopharmaceuticals

Suspension from QuotationSep 22
Phase 3 Interim Result Below Continuation ThresholdSep 23
Notification of cessation of securities - PARSep 24
Agreement to Return US$2M to ObsidianSep 24
Continuation of Voluntary SuspensionSep 27

All Paradigm Biopharmaceuticals news releases

Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.

Follow Paradigm Biopharmaceuticals